Should you buy 2637.HK stock?
Last updated:
Based on market data through , StockInvest.us rates Fujian Haixi Pharmaceuticals Co., Ltd. (2637.HK) as Hold/Accumulate with a technical score of -0.10 on its -10 to +10 scale. The rating is unchanged from the previous daily evaluation.
- Hold signal since
- Price since signal Up 0.50%
- 3-month trend forecast Down 17.98%
- Easy Tracking In The Watchlist
Red day on Tuesday for Fujian Haixi Pharmaceuticals Co., Ltd. stock after losing 0.89%
(Market data through Aug 11, 2026)
The Fujian Haixi Pharmaceuticals Co., Ltd. stock price fell by -0.89% on the last day (Tuesday, 11th Aug 2026) from HK$202.60 to HK$200.80. During the last trading day the stock fluctuated 2.79% from a day low at HK$200.80 to a day high of HK$206.40. The price has been going up and down for this period, and there has been a 17.43% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -120 thousand shares and in total, 96 thousand shares were bought and sold for approximately HK$19.31 million.
The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is HK$196.43, a level that may pose a second chance to hit a runner. According to fan-theory HK$256.48 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.
2637.HK Signals & Forecast
The Fujian Haixi Pharmaceuticals Co., Ltd. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at HK$194.53 and HK$187.35. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, July 07, 2026, and so far it has fallen -6.08%. Further fall is indicated until a new bottom pivot has been found. Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.
Support, Risk & Stop-loss for Fujian Haixi Pharmaceuticals Co., Ltd. stock
Fujian Haixi Pharmaceuticals Co., Ltd. finds support from accumulated volume at HK$199.40 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved HK$5.60 between high and low, or 2.79%. For the last week, the stock has had daily average volatility of 5.78%.
Our recommended stop-loss: HK$192.15 (-4.31%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 25 days ago.)
Trading Expectations (2637.HK) For The Upcoming Trading Day Of Wednesday 12th
For the upcoming trading day on Wednesday, 12th we expect Fujian Haixi Pharmaceuticals Co., Ltd. to open at HK$202.67, and during the day (based on 14 day Average True Range), to move between HK$194.34 and HK$207.26, which gives a possible trading interval of +/-HK$12.93 (+/-6.65%) up or down from last closing price. If Fujian Haixi Pharmaceuticals Co., Ltd. takes out the full calculated possible swing range there will be an estimated 6.65% move between the lowest and the highest trading price during the day.
Since the stock is closer to the support from accumulated volume at HK$199.40 (0.70%) than the resistance at HK$203.00 (1.10%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..
Is Fujian Haixi Pharmaceuticals Co., Ltd. stock A Buy?
Fujian Haixi Pharmaceuticals Co., Ltd. holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Current score:
-0.103
Hold/Accumulate
Unchanged
Predicted Fair Opening Price
Predicted fair opening price on August 12, 2026 - HK$202.67 ( 0.93%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
2637.HK Performance
Trading levels for 2637.HK
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 208.27 | 3.72% |
| R2 | 206.13 | 2.65% |
| R1 | 204.81 | 1.99% |
| Price | 200.80 | |
| S1 | 200.53 | -0.136% |
| S2 | 199.21 | -0.794% |
| S3 | 197.07 | -1.86% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 236.60 | 17.83% |
| R2 | 207.20 | 3.19% |
| R1 | 203.00 | 1.10% |
| Price | 200.80 | |
| S1 | 199.40 | -0.697% |
| S2 | 180.00 | -10.36% |
| S3 | 160.00 | -20.32% |
FAQ
Click here for our free guide on how to buy Fujian Haixi Pharmaceuticals Co., Ltd. Stock.
Buy 2637